Biotech

All Articles

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund from Bain Resources Life Sciences, Arc Endeavor Partners is confi...

Orion to use Aitia's 'digital twins' to discover brand new cancer medicines

.Finnish biotech Orion has spied potential in Aitia's "electronic identical twin" tech to build new ...

Windtree's surprise med rears blood pressure in newest phase 2 win

.While Windtree Therapeutics has strained to grow the economic origins needed to survive, a period 2...

2 cancer biotechs merge, producing global footprint

.OncoC4 is taking AcroImmune-- and also its internal professional production abilities-- under its f...

Amgen files initial stage 3 gain for $400M eczema drug

.Amgen has actually shared (PDF) the very first stage 3 records on its own $400 thousand eczema medi...

Biogen, UCB record phase 3 lupus win after falling short earlier test

.Biogen as well as UCB's bank on developing into stage 3 on the back of a broken research aims to ha...

Aptadir hopes new RNA inhibitors can turn around complicated cancers cells

.Italian biotech Aptadir Rehabs has released with the assurance that its pipeline of preclinical RNA...

Wave surfs DMD effectiveness to regulators' doors, sending out stockpile

.Wave Life Sciences has actually met its own target in a Duchenne muscular dystrophy (DMD) study, po...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, using up ...

Achilles droplets tissue therapy plan, bandages for cutbacks after missing 'commercial stability' targets

.Achilles Therapeutics has actually destroyed its own method. The English biotech is actually stoppi...